Roflumilast – (162401-32-3)

Roflumilast is a molecule used for the treatment of chronic obstructive pulmonary disease (COPD), plaque psoriasis, seborrheic dermatitis, and atopic dermatitis.

It acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4), exhibiting anti-inflammatory effects.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Roflumilast is a molecule used for the treatment of chronic obstructive pulmonary disease (COPD), plaque psoriasis, seborrheic dermatitis, and atopic dermatitis.

It acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4), exhibiting anti-inflammatory effects.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
Sources:
https://en.wikipedia.org/wiki/Roflumilast
https://www.medchemexpress.com/Roflumilast.html
https://www.medkoo.com/products/6523
https://go.drugbank.com/drugs/DB01656
Other Names

DAXAS, Daliresp

IUPAC Name

3-(cyclopropylmethoxy)-N-(3, 5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide

CAS

162401-32-3

Molecular Weight

403.2

Molecular Formula

C17H14Cl2F2N2O3

SMILES

C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F

No products in the cart.